Important notice:Lime Trading (CY) Ltd has ceased providing its services to the UK market and UK resident investors and as a result shall exit the UK Temporary Permissions Regime (TPR) by year-end 2023, and any related UK consumer protections shall not apply from that point onwards. The Company shall remain licensed and regulated by the Cyprus Securities and Exchange Commission (CySEC).
х
Risk warning:
Trading on financial markets carries risks. The value of the investments can both increase and decrease and the investors may lose all their investment capital. In case of a leveraged product, the loss may be more than the initial capital invested. Detailed information on risks associated with trading on financial markets can be found in General Terms and Conditions for the Provision of Investment Services.
Intellia Therapeutics, Inc. (NASDAQ: NTLA) rose 28.9% to $114.49 in pre-market trading. Intellia Therapeutics and Regeneron Pharmaceuticals disclosed positive interim data from Phase 1 clinical study of their lead in vivo genome editing candidate, NTLA-2001, an investigational CRISPR therapy for transthyretin (ATTR) amyloidosis.
Mexco Energy Corporation (NYSE: MXC) rose 22% to $10.99 in pre-market trading after the company swung to a profit for FY21.
Arbutus Biopharma Corporation (NASDAQ: ABUS) shares rose 17.6% to $3.96 in pre-market trading after the company reported new data on AB-729 and AB-836 programs with presentation of five abstracts at the EASL International Liver Congres 2021.
MediWound Ltd. (NASDAQ: MDWD) shares rose 14.9% to $6.56 in pre-market trading after surging over 14% on Friday.
Editas Medicine, Inc. (NASDAQ: MDWD) rose 10.9% to $46.45 in pre-market trading after gaining over 2% on Friday.
CEL-SCI Corporation (NYSE: CVM) shares rose 10.1% to $27.60 in pre-market trading. The company, earlier during the month, announced a bought deal offering of $31.7 million.
Senseonics Holdings, Inc. (NYSE: SENS) rose 8.9% to $4.17 in pre-market trading as the company's stock will be added to the Russell 3000 today.
CRISPR Therapeutics AG (NASDAQ: CRSP) rose 8.1% to $154.00 in pre-market trading after gaining over 3% on Friday.
Iterum Therapeutics plc (NASDAQ: ITRM) rose 7.7% to $2.23 in pre-market trading after gaining around 2% on Friday.
Virgin Galactic Holdings, Inc. (NYSE: SPCE) rose 6.4% to $59.50 in pre-market trading after jumping around 39% on Friday.
Express, Inc. (NYSE: EXPR) rose 5.7% to $7.50 in pre-market trading after surging 24% on Friday.
Marin Software Incorporated (NASDAQ: MRIN) shares rose 5.5% to $4.02 in pre-market trading. Marin Software shares gained over 8% on Friday after the company on Wednesday announced it has added the ability to manage Instacart Ads to its flagship MarinOne platform.
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 5.3% to $1.99 in pre-market trading. Corbus Pharmaceuticals, last week, reported its DETERMINE Phase 3 study of lenabasum for treatment of dermatomyositis did not meet the primary endpoint.
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
Greenland Technologies Holding Corporation (NASDAQ: GTEC) fell 15.4% to $7.67 in pre-market trading after the company reported a proposed underwritten public offering of ordinary shares.
IKONICS Corporation (NASDAQ: IKNX) shares fell 10.2% to $16.66 in pre-market trading. IKONICS shares jumped 64% on Friday after the company, and TeraWulf, announced a merger agreement.
Missfresh (NASDAQ: MF) shares fell 8.2% to $8.87 in pre-market trading. The company, on Friday, priced its IPO at $13 per share.
Grove, Inc. (NASDAQ: GRVI) fell 7.8% to $7.25 in pre-market trading after jumping 40% on Friday. The company, last week, priced its IPO at $5 per share.
Atossa Therapeutics, Inc. (NASDAQ: ATOS) fell 7.8% to $7.95 in pre-market trading after gaining around 9% on Friday. The company is set to be included in the Russell 2000, 3000 indices, effective today.
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) fell 7.5% to $7.30 in pre-market trading. Acurx Pharmaceuticals shares climbed over 31% on Friday after the company priced its IPO at $6 per share.
Osmotica Pharmaceuticals plc (NASDAQ: OSMT) shares fell 5.8% to $3.56 in pre-market trading. Osmotica Pharmaceuticals shares jumped 33% on Friday after the company agreed to sell its portfolio of legacy products and Georgia manufacturing facility, for up to $170 million, to Alora Pharmaceuticals LLC..
BurgerFi International, Inc. (NASDAQ: BFI) fell 4.1% to $9.76 in pre-market trading. BurgerFi International set to join the Russell Microcap® Index, effective today.
